$ZD

Ziff Davis Q2 Earnings Call Highlights

Ziff Davis (NASDAQ:ZD) reported Q2 call highlights. Advertising and performance-marketing revenue fell 6% YoY and subscription and licensing revenue was flat. Other revenue rose over 2x, up about $3.7M, mainly from Semantic Labs. Cash was $1.6B and long-term investments $100M. The company accelerated buybacks, repurchasing 2.6M shares for $121.5M, and expects Q3 revenue to rise sequentially but fall YoY.

Original reporting
Published Aug 9, 2026, 4:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 9, 2026, 4:54 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Ziff Davis Q2 Earnings Call Highlights — source image
Decision brief

The 30-second read

$ZDNeutralMed
01

Why it matters

Key decision inputs are the company’s Q3 and Q4 directional guidance, the pace of share repurchases, and management’s explanation for search traffic pressure and advertising softness in specific brands (IGN, MedPage Today).

02

Market read

Traders can update positioning based on management’s Q3 revenue decline expectation (YoY) despite sequential growth, margin modest improvement, and continued buyback acceleration.

03

What to watch

The guidance is directional but lacks quantified revenue/EBITDA margin ranges; the magnitude of sequential improvement and the extent of MedPage and IGN ad stabilization could drive the stock more than the headline revenue trends.

Relevance 7/10Novelty 6/10Timing: post-earnings call, pre-market positioning for Q3/Q4 expectations

Background

The piece summarizes Ziff Davis Q2 earnings call themes across revenue segments, capital allocation, and AI product-development strategy.

Company-level read

Ticker impact

$ZDNeutralMedium confidence
Context

Ziff Davis guided Q3 revenue to rise sequentially but decline low- to mid-single digits YoY, with modest adjusted EBITDA margin improvement.

Expected impact

Near-term trading likely hinges on how investors weigh search traffic pressure and segment revenue declines versus margin support and buyback pace.

Evidence & confidence

The article provides forward-looking Q3 and Q4 directional guidance, detailed buyback deployment, and specific drivers (search AI overviews share, IGN ad weakness, MedPage customer budget shifts).

Market effects

Digital media and performance marketing peers may face similar search-distribution and ad-spend shifts toward lower-cost AI platforms.

No specific regional impact beyond US-listed media and ad-tech sentiment.

Limited direct global read-through; mostly company-specific guidance and AI-development process changes.

Counterpoint

Investors may be underestimating the durability of affiliate and social monetization as search traffic mix shifts toward AI overviews.

Key entities

  • Ziff Davis

    Digital media and internet company operating PCMag, IGN, and performance marketing platforms; provided Q2 highlights and Q3/Q4 directional guidance.

  • OpenAI

    Referenced in ongoing litigation tied to Ziff Davis’ AI content licensing stance.

  • Google AI Overviews

    Management cited rising share of relevant queries showing Google AI Overviews, indicating distribution pressure on traditional search.

Related articles

$ZDMedAI 8/10

Ziff Davis (ZD) Q2 2026 Earnings Call Transcript

Ziff Davis (ZD) reported Q2 2026 revenue of $286.7 million, down 2.7% YoY, and adjusted EBITDA of $76.8 million, down 3.7% with a 26.8% margin. Adjusted diluted EPS rose to $1.03 on lower share count. The company sold Connectivity to Accenture for $1.2 billion, repurchased 2.6M shares for $121.5M, and expects sequential Q3 revenue growth.

$ZDMed

Ziff Davis Reports Second Quarter 2026 Financial Results

ZIFF DAVIS, INC. (ZD) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ziff Davis Reports Second Quarter 2026 Financial Results NEW YORK, NY -- August 6, 2026 -- Ziff Davis, Inc. (NASDAQ: ZD) (“Ziff Davis” or “the Company”) today reported unaudited financial results for the second quarter ended June 30, 2026. “With the successful sale o

$ZDLow

ZIFF DAVIS, INC. (ZD): Completion of Acquisition or Disposition of Assets

ZIFF DAVIS, INC. (ZD) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-10.1 2 exhibit101ziffdavis-connec.htm EX-10.1 Document EXHIBIT 10.1 June 15, 2026 Reference is made to the Credit Agreement, dated as of April 7, 2021 (as the same has been amended, and as the same may be amended, restated, supplemented or otherwise modified from time to time,

$RDYMed

Dr Reddy's Laboratories Ltd (RDY) (Q2 2027) Earnings Call Highlights: Margin Recovery

Dr. Reddy's Laboratories reported a 1.5% year-over-year revenue decline, driven by lower lenalidomide sales and declines in North America, Europe, and PSAI businesses. The company expects margins to improve with new products and business mix, targeting a 55% gross margin. Semaglutide relaunch is planned for November 2026, and abatacept biosimilar approval is expected by December 2026.

$BCSMedAI 8/10

Barclays Posts £2.3bn Q3 Profit and Plans 5,000 Job Cuts

Barclays reported a 12% rise in Q3 pre-tax profit to £2.3bn, driven by revenue growth and lower impairment charges. The bank announced a £500m share buyback and plans to cut 5,000 jobs. Revenue increased 3% to £7.4bn, while earnings per share rose 18%. Trading revenues showed mixed results, with equities up 47% and fixed income down 19%. Shares fell over 2.5% post-announcement.

$FIXMed

Comfort Systems USA Inc (FIX) (Q3 2026) Earnings Call Highlights: Record

Comfort Systems USA (FIX) reported Q3 2026 earnings, with record bookings driven by new and existing customers. Gross margins declined due to higher equipment/materials costs and purchase accounting adjustments. Backlog duration extended to 18-24 months, potentially delaying revenue recognition. Labor constraints and high acquisition pricing were noted. The company expects margin normalization in early 2027 and remains cautious about adding new programmatic modular customers.